Click on image to view this TV comercial

[voice-over] What are you gonna miss when you have an allergy attack? Benadryl is more effective than Claritin in relieving your worst symptoms: runny nose, sneezing and watery eyes and works when you need it most.

Benadryl, you can’t pause life.

New Benadryl kapgels, the same effective relief you trusted with cap seals now in a kapgel.

Click on image to view this TV comercial

[voice-over] Allergies can make them miss-out. Children’s Benadryl effectively relieves your child’s allergy symptoms. Like runny nose, sneezing and itchy eyes. It works when they need it most.

Children’s Benadryl, you can’t pause life.

Print ad

You would have watched your husband build a campfire with his own two hands. Well, his own two hands, 38 matches, a liter of kerosene and your map.

Allergies can be unpredictable. Don’t miss out on the moment.

Benadryl is more effective than Claritin at relieving your worst allergy symptoms. And works when you need it most.

Brand name: Benadryl
Generic name/category: Diphenhydramine hydrochloride, antihistamine, antiemetic, sedative, and hypnotic
Company: McNeil-PPC a division of Johnson & Johnson
Country/Market: USA, North America
Indication(s)/use: cough and cold relief
Target: Consumers (DTC)
Tagline: You can’t [pause] life.
Publication: People Magazine June 1 2009

To see all of this brand’s ads on AdPharm, click here

Agency: Bangkok Showcase, Bangkok, Thailand
Executive Creative Director: Chukiat Koosongdham
Art Director: Chokchai Tupanyakanok
Copywriter: Nattawut Sittiwaraphan
Photographers: Chup Nokkeaw, Chubcheevit

Brand name: FootaSep
Generic name/category: Foot deodorant
Country/Market: Thailand, Asia
Indication(s)/use: foot smell
Target: Consumers (DTC)
Publication: 2009

Open up new horizons

Room temperature stable.

NovoSeven room temperature stable. Always at hand.

Targeted bleeding control.

Recombinant human factor VIIa (NovoSeven, eptacog alfa [activated], ATC code B02BD08) has been introduced for use in uncontrollable bleeding in hemophilia patients (with Factor VIII or IX deficiency) who have developed inhibitors against replacement coagulation factor.

It is being increasingly used in uncontrollable hemorrhage. The first report of its use was in an Israeli soldier with uncontrollable bleeding in 1999. The rationale for its use in hemorrhage is, that it will only induce coagulation in those sites where tissue factor (TF) is also present. Still, O’Connell et al. report an increased risk of deep vein thrombosis, pulmonary embolism and myocardial infarction in association with the use of rhFVIIa.

According to a 2005 study, recombinant human factor VII improves outcomes in acute intracerebral hemorrhage.

More on Wikipedia

Agency: Life Healthcare

Brand name: NovoSeven
Generic name/category: Eptacog alfa (activated)
Company: Novo Nordisk
Country/Market: UK, Europe
Indication(s)/use: uncontrollable hemorrhage
Target: Healthcare Professionals (HCP)
Tagline: Targeted bleeding control.